STUNELL BACKS PLANS TO SAVE MORE LIVES IN STOCKPORT


Hazel Grove MP Andrew Stunell backed Cancer Research UK’s new plan to help save more lives in Stockport and all across the North West. 

Cancer Research UK has set itself an ambition that within 20 years three in Cancer_Research_July_2014.jpgfour of all cancer patients diagnosed will survive at least ten years.  Two in four people diagnosed with cancer today in the UK will survive their disease for at least ten years, compared to just one in four in the early 1970s. In the North West, this means that around 19,000 people each year can now expect to survive the disease for at least ten years.

 

Commenting, Andrew Stunell MP said - “The good news is that there have been significant steps forward for cancer patients. More people are surviving the disease and living longer and Cancer Research UK’s work has been at the heart of this progress.” 

 

“But there is more to be done to help people beat cancer. I wholeheartedly support Cancer Research UK’s aim to improve survival through the earlier diagnosis of cancer and greater access to the best treatment possible.”

 

Currently the one-year cancer survival rate in Stockport (70.8%) is similar to the English average (68.2%), however the English average is lower than most other countries in Europe, so there is much room for improvement.   

 

Sara Osborne, Head of Policy at Cancer Research UK said: “It’s great to have Sir Andrew’s support to highlight the vital role MPs and their constituents can play in helping to tackle all cancers.

 

“As more people are diagnosed with the disease, it’s essential that we speed up our progress. We know that early diagnosis and access to the best possible treatments saves lives. We need the public and MPs to get behind us and help make our ambition possible. In the next two decades we can, and will, transform the outlook for cancer patients.”

 

For more information on how to get involved in Cancer Research UK’s campaigning work, visit cruk.org/campaigns.


Share this post on social media:

Sign in with Facebook, Twitter or Email.